Kongpakwattana, Khachen
Ademi, Zanfina
Chaiyasothi, Thanaputt
Nathisuwan, Surakit
Zomer, Ella
Liew, Danny
Chaiyakunapruk, Nathorn http://orcid.org/0000-0003-4572-8794
Article History
First Online: 26 June 2019
Compliance with Ethical Standards
:
: No sources of funding were used to conduct this study or prepare this manuscript.
: DL has received research grants and consulting fees and from companies for work unrelated to this study. ZA and EZ have received grants for the assessment of evolocumab from an Australian perspective. KK, TC, SN, and NC have no conflicts of interest that are directly relevant to the content of this review/study.